Sign In
Buy SNN
$31.56
-0.770 (-2.38%)
At Close: Jul 31, 2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI – leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence
Scar Treatment Market Booms with Rising Skin-Related Surgeries and Burn Cases Globally Scar Treatment Market Booms with Rising Skin-Related Surgeries and Burn Cases Globally
SNN Stock May Gain on CORIOGRAPH Platform's FDA Clearance for THA
10:06am, Friday, 20'th Dec 2024
Smith & Nephew announces FDA clearance for its CORIOGRAPH platform for total hip arthroplasty.
Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty
10:00am, Thursday, 19'th Dec 2024
Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for patients and surgeons Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today annou
SNN Stock Might Rise Following FDA Nod for AETOS Stemless
08:45am, Tuesday, 17'th Dec 2024
Smith & Nephew received FDA 510(k) clearance for a stemless anatomic total shoulder, AETOS Stemless. This represents a significant advancement in shoulder arthroplasty.
Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty
10:00am, Monday, 16'th Dec 2024
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total
Smith & Nephew has the potential to pop next year, says leading US investment bank
06:44am, Tuesday, 03'rd Dec 2024
JP Morgan has doubled down on its "overweight" recommendation for Smith & Nephew PLC (LSE:SN) with its analysts deeming the medical device company undervalued, trading near trough levels, with potent
Big investors call for break-up of Smith & Nephew, FT reports
12:24am, Thursday, 14'th Nov 2024
Three major investors are pushing medical device maker Smith & Nephew to consider a break-up of the business, the Financial Times reported on Thursday, citing shareholders.
Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends
01:02pm, Sunday, 10'th Nov 2024
Smith & Nephew's Q3 results led to a 13% share price drop due to reduced FY24 guidance, mainly from lower demand in China. Despite short-term challenges, long-term fundamentals remain strong, presenti
Smith & Nephew plc (SNN) Q3 2024 Earnings Conference Call Transcript
08:57am, Saturday, 02'nd Nov 2024
Smith & Nephew plc (NYSE:SNN ) Q3 2024 Earnings Conference Call October 31, 2024 4:30 AM ET Company Participants Deepak Nath - CEO & Director John Rogers - CFO & Executive Director Conference Call Par
Smith+Nephew slashes revenue outlook as China headwinds emerge
04:16am, Thursday, 31'st Oct 2024
British medical equipment manufacturer Smith & Nephew PLC (LSE:SN) slashed its full-year revenue outlook to account for a downturn in demand and pricing pressures in the Chinese market. The FTSE 100-l
Smith & Nephew slashes annual revenue forecast on weak China
03:17am, Thursday, 31'st Oct 2024
British medical equipment maker Smith & Nephew cut its annual underlying revenue growth forecast on Thursday to 4.5% from the previous outlook range of 5% to 6%, primarily hurt by challenges in its su
RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design
09:00am, Wednesday, 16'th Oct 2024
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design
SNN Stock May Gain Following the Co-Marketing Deal With JointVue
01:36pm, Tuesday, 15'th Oct 2024
Smith & Nephew and JointVue announce a co-marketing agreement for the latter's OrthoSonic 3D Surgery Planning Technology.
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System
10:16am, Friday, 11'th Oct 2024
Smith & Nephew introduces the LEGION Hinged Knee System with OXINIUM Technology, elevating knee revision surgery through innovation.
